These authors contributed equally to this work.
Human CD14+CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma
Article first published online: 23 DEC 2013
© 2013 by the American Association for the Study of Liver Diseases
Volume 59, Issue 2, pages 567–579, February 2014
How to Cite
Han, Y., Chen, Z., Yang, Y., Jiang, Z., Gu, Y., Liu, Y., Lin, C., Pan, Z., Yu, Y., Jiang, M., Zhou, W. and Cao, X. (2014), Human CD14+CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma. Hepatology, 59: 567–579. doi: 10.1002/hep.26694
This work was supported by grants from the MOST 125 Major Project of China (2012ZX10002014-001 and 2012ZX10002010), the National Key Basic Research Program of China (2011CB965202, 2013CB530503, and 2013CB944903), the National Natural Science Foundation of China (31170843), and the Foundation for the Author of National Excellent Doctoral Dissertation of China (201071).
Potential conflict of interest : Nothing to report.
- Issue published online: 29 JAN 2014
- Article first published online: 23 DEC 2013
- Accepted manuscript online: 19 AUG 2013 10:32AM EST
- Manuscript Accepted: 11 AUG 2013
- Manuscript Received: 1 APR 2013
This article has been cited by:
- 2Intratumoral dendritic cells in the anti-tumor immune response, Cellular and Molecular Immunology, 2015,, ,
- 3The origin and function of tumor-associated macrophages, Cellular and Molecular Immunology, 2015, 12, 1, 1, ,
- 4The yin and yang of evasion and immune activation in HCC, Journal of Hepatology, 2015,, , , ,
- 5Tolerogenic dendritic cells and their applications in transplantation, Cellular and Molecular Immunology, 2015, 12, 1, 24, ,
- 6Human hepatocellular carcinoma-infiltrating CD4+CD69+Foxp3− regulatory T cell suppresses T cell response via membrane-bound TGF-β1, Journal of Molecular Medicine, 2014, 92, 5, 539, , , , , , , , , , ,
- 8Immunotherapy of hepatocellular carcinoma, Hepatic Oncology, 2014, 1, 4, 433, , ,
- 9Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab, Journal for ImmunoTherapy of Cancer, 2014, 2, 1, 31, , , , , , , , , , , ,
- 10Th1 cytokine-based immunotherapy for cancer, Hepatobiliary & Pancreatic Diseases International, 2014, 13, 5, 482,